Indian pharma’s US tripping benefits MNCs, Business Standard, July 07, 2014

Med representative’s job partly vanishing, Business Standard, October 16, 2013

Blow to another MNC as patent for GSK’s drug revoked, Business Standard, August 3, 2013

Domestic drug prices immune to pharma acquisitions, The Financial Express, June 12, 2013

Ranbaxy case may take a toll on other Indian drug makers, Business Standard, May 24, 2013

Indian pharma under the microscope, Mint (WSJ), May 24, 2013

New drug policy to negatively impact pharma sector: Industry, Economic Times, May 17, 2013

New drug policy to hit profitability of firms, Business Today, May 17, 2013

Pharma giants may go slow on Indian R&D, The Financial Express, April 4, 2013

Activists, patients’ bodies hail patent ruling
Industry rings a warning, The Telegraph, April 2, 2013

Union Budget 2013 – Dashed hopes, Express Pharma, March 13, 2013

Nothing significant in this budget for the healthcare sector: Tapan Ray, Business Today, March 1, 2013

Budget Reactions: NRUHM only cheer in pharma-silent Budget: Pharma body,, March 1, 2013

Mixed reactions to the budget 2013-14, Pharmabiz, March 01, 2013

India Plans Price Controls for Patented Drugs, The Wall Street Journal, February 27, 2013

Compulsory licenses may spur more voluntary licensing deals, Mint (WSJ), January 25, 2013

India Battles For Right To Use Compulsory Licenses To Make Medicines Affordable,
Third World Network on Intellectual Property Issues,  22 January 2013

2013: A year of short-term pain, for long-term gain? Express Pharma, December 31, 2012

Poor may suffer as India caps drug prices, Nature, December 14, 2012

New drug pricing policy may hit profitability of firms, Live Mint, WSJ, December 11, 2012

Novartis vs India – Supreme Court hearing ends, Express Pharma, December 5, 2012

Big Pharma on the backfoot in India, Business Today, November 30, 2012

New drug policy will hurt investment in pharma sector: Industry, NDTV Profit, November 25, 2012

New drug policy will hurt investment in pharma: Industry,, November 25, 2012

‘New drug policy will hurt Pharma sector’, The Indian Express, November 25, 2012

New drug policy will hurt investment in pharma sector: Industry, Economic Times, November 25, 2012

New drug policy will hurt investments in the sector, Business Standarf, November 25, 2012

Govt paves way for controlling price of esential drugs through National Pharmaceutical Pricing Policy, India Today, November 23, 2012

On The Freeway To Health, Businessworld, November 9, 2012

SC Asks Centre Not To Alter Drug Pricing System, Businessworld, October 3, 2012

Ministerial panel seeks price control for 348 essential drugs, Free Press Journal, September 28, 2012

Price control list may have 274 more drugs, DNA, September 27, 2012

GoM Nod to Bring 348 Essential Drugs Under Govt Control, Outlook, September 28, 2012

New policy prescription: price control on 348 drugs, Financial Chronicle, September 28, 2012

Commonly used drugs may get cheaper, Live Mint, September 28, 2012

348 essential drugs may turn cheaper as Ministers’ panel suggests price control, Business Line, September 28, 2012

GoM finalises pricing policy for 348 drugs, The Economic Times, September 28, 2012

GoM finalises pharma pricing policy, to cover 348 drugs, Zee Business, September 28, 2012

Unavailability of products with chemists concerning: report, The Economic Times, September 17, 2012

Unavailability of medicines at retailer’s end a concern: Report, Business Standard, September 17, 2012

The big pharma feud, The Times of India, Crest Edition, September 15, 2012

Sustaining growth of pharmaceutical industry in long term a challenge, says top pharma body, The Economic Times, September 15, 2012

‘Sustaining growth of pharma industry in long term a challenge’, The Indian Express, September 15, 2012

Pricing of imported drugs under regulatory scanner, Economic Times, September 6, 2012

India Looks To Expand Drug-Price Controls, Wall Street Journal, September 5, 2012

FDI tangle: And the vote goes to….?, Express Pharma, August 27, 2012

Gearing up for the biosimilar boom, Express Pharma, August 21, 2012

Improving access, innovation, reach key to achieving UHC , Express Pharma, August 21, 2012

Novartis Fights India for Cancer Pill Patent, The Wall Street Journal, August 19, 2012

Prices of patented medicines may come down by a third if panel’s recommendation accepted, Economic Times, August 16, 2012

Big Pharma lobbies hard to curb generics, Times of India, August 16, 2012

Generic business may hit drug exports of Indian firms like Cipla and Natco, The Economic Times, August 3, 2012

OPPI conclave focuses on accessibility of healthcare to all, with special focus on innovation, Pharmabiz, July 30, 2012

Innovative drug companies committed to improve access in India: OPPI conclave, Pharma Age, July 28, 2012

Innovative drug companies committed to improving access in India: OPPI, Express Pharma, July 27, 2012

Free generics for India’s poor but big pharma misses out, Chemistry World, RSC, July 25, 2012

ACTA Down, but What Next?, Express Pharma, July 18, 2012

US steps up lobbying efforts against compulsory licensing, Live Mint (WSJ), July 17, 2012

Strong medicine, Time of India, Crest Edition, July 14, 2012

India’s Plan To Distribute Free Medicines Raises Questions, The Wall Street Journal, India, July 6, 2012

India to give free medicine to hundreds of millions, Deccan Herald, July 5, 2012

More nations adopting Indian intellectual property regulations for drug manufacturing, Economic Times, June 22, 2012

FIPB may be allowed to clear foreign buys in pharma companies, Economic Times, May 16, 2012

Pharma companies open to milder alternative pricing mechanism, Economic Times, May 16, 2012

Probe finds collusion between drug regulator, pharma firms, Deccan Herald, May 10, 2012

Health panel rap to drug regulator, boost for consumers, Hindu Business Line, May 9, 2012

Probe finds collusion between drug regulator, pharma firms, First Post, May 9, 2012

Indian drug regulator accused of malpractice, Financial Times, London, May 9, 2012

Unclear rules stop FDI in pharma companies, Economic Times, May 8, 2012

DoP says competition doesn’t always lead to cheaper drugs; raises concern among industry, Economic Times, April 30, 2012

Natco gets India’s first compulsory licence, Live Mint (WSJ), March 13, 2012

Natco Pharma bags licence to sell Bayer’s cancer drug Nexavar, Economic Times, March 13, 2012

MNCs circle, descend on Indian vaccine market, Business Standard, March 11, 2012

Bulk drugs should remain under price control, say pharma MNCs, Financial Express, December 17, 2011

Rs.3,000 crore loss to industry if draft drug policy implemented, LiveMint (WSJ), December 6, 2011

New policy to force cut in imported drug prices, Economic Times, November 3, 2011

Delay in CCI as regulator for pharma deals irks MNCs, Financial Express, October 24, 2011

Ministry proposal on FDI cap in pharma sector faces criticism, LiveMint (WSJ), September 23, 2011

MNC drug-makers allay fears of rise in prices, The Hindu Business Line, August 3, 2011,

Kurian quits as Patent Office Chief,LiveMint (WSJ),June 15, 2011

Strong dose: Govt ay make pharma code mandatory, Times of India, June 7, 2011

Government drafts official code of marketing practices for pharma industry,
Economic Times, June 4, 2011

Details of patented drugs to be made public,
Live Mint (WSJ), May 23, 2011

Express Pharma, April 1-15, 2011

Pharma FDI over 49% may need FIPB nod;
The Financial Express, Tue, 5 Apr 2011

Foreign takeovers of Indian drug companies fuel fear of rising prices;
The Washington Post. March 11, 2011

Natco seeks Pfizer nod for drug clone,
The Economic Times, January 5, 2011

New pharma policy to focus on cheaper drugs for poor,
Financial Express, December 15, 2010

US trade representative finds fault with India, China intellectual property regimes,
Livemint, Nov 24, 2010

Pharma Leaders Shine At Nation’s Biggest Leadership Meet & Awards,
June 29, 2010

US Healthcare Reforms to aid BPOs,
Hindustan Times, June 26, 2010

Credibility crisis looms as Indian medical council is dissolved,
Scrip, 18 May 2010

OPPI upset over poor cold room storage facility at airports,
Pharmabiz, May 7, 2010

Bionomics of biosimilars – Indian opportunities,
May 5, 2010

World IP Day,
ITAG. April 26, 2010

Cipla offers govt low-cost drug technology to fight cancer, AIDS,
Live Mint (WSJ). April 21, 2010

4th Health & Youth Conference,
J.W. Marriott Hotel, Seoul, Korea, April 15, 2010

Indian Pharmaceutical Alliance Defends Section 3(d) Of Patents Act, Says Statute Not Against Incremental Innovations ,
PharmAsia News, Bio-Pharma Today April 7, 2010

Pfizer, Novartis and Eli Lilly got bulk of contentious patents,
Live Mint (WSJ). April 6, 2010

A balanced budget, but not much for pharma,
Express Pharma. March 16-31, 2010

Indian ethics code: Will industry self-regulation suffice?
Scrip, 19 March 2010

Indian ethics code: Will industry self-regulation suffice?
Scrip, 19 March 2010

Pharma biggies disclose payments made to doctors ctors,
Times of India, 1-February-2010

Pharma firms reveal payments to doctors,
Times of India, 1-February-2010

Bionomics of Biosimilars,
Biospectrum, January 13, 2010

Small pharma cos oppose self-regulation for industry, want rules,
The Economic Times, December 11, 2009

Breaking an unholy alliance,
The Telegraph, November 23, 2009

Doctorss told not to accept gifts from drug companies,
The Economic Times, November 16, 2009

Prescriptions Without Motives,
Businessworld, November 16, 2009

Generics Gateway,
November 09, 2009

Low imports from China lead to 15% shortage in drugs,
DNA, November 6, 2009

Opportunities and challenges in the health marketing space,
The Times of India, October 14, 2009

October 5, 2009

Patent experts pool being set up to advise courts

Board of Directors Shasun (SCDL)

Indian industry divided over review of 86 patents.pdf

IIPS Advisory Board, NMIMS University

New ‘cold chain’ facility for Delhi airport

Cambridge-India Partnership, University of Cambridge, February, 2009

Delhi HC directs DCGI not to permit generic drugmakers for drugs already patented

Protect or Perish

Business, India Infoline News Service / Mumbai Dec 16, 2008

BioSpectrum Awards

WHO won’t redefine fake drugs

Pharma families of India -Towards a new dawn


DCGIs plan on patent linkage gets HC booster

Relax export norms to tap global clinical R&D market.pdf

Pharma MNCs ask DCGI to liaison with patent offices.pdf

OPPI, IDMA come out with contrasting views on definition of counterfeit drugs.pdf

Chineese move queers pharma pitc, DNA Money, July 27, 2008

OPPI seeks 6-month deadline for pre-grant oppositions.pdf

OPPI Appoints Imprimis PR As Its Communications Partner.pdf

Ocimum Biosolutions CEO wins Astia and Biospectrum awards.pdf

No relief for cancer patients-drugs still cost more in India.pdf

More knocks than praise as transparency remains key issue.pdf

MNC pharma firms told to launch latest drugs in India.pdf

India, China pharma cos need to leverage knowledge capital.pdf

Govt may use compulsory licensing for drug companies only in emergency.pdf

Faster drug price revision booster shot for pharma.pdf

Ex parte order to Bristol-Myers setback to Indian drug industry.pdf

Drug firms may stop freebies to doctors.pdf

DCGI’s plan to patent linkage gets HC booster.pdf

Ocimum Biosolutions CEO wins Astia and Biospectrum awards. Indiainfoline, December 16, 2008

Healthcare and Pharma Conclave, Indian School of Business (ISB) September 26-27, 2008

Are your drugs boosting your doctor’s lifestyle? December 15, 2008

No relief for cancer patients—drugs still cost more in India. Mint, June 28, 2008

Hijack At Pill Point. May 19, 2008

Budget Speak 2008.pdf

Budget 2008-09 satisfactory, says industry.pdf

Members of Council, IFPMA, Geneva, Switzerland

Abbot launches health drink, Business Line, Thursday, March 30, 2000